Author： Goldman S.A.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.27, Iss.8, 2004-01, pp. : 519-534
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IV corticosteroids in COPD exacerbations: is 3 days enough?
Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. :
Access to resources
Recommend
Standard short-course TB therapy not enough?
Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. :
Outstanding research into pandemic flu - but is it enough?
Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. :
Incentives have impact in rural India, but is it enough?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 604, 2010-01 ,pp. :
Valsartan cost effective in HF?
Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. :